Adlai Nortye ANL
NASDAQ ANL
$15.01 +0.26 (+1.76%)
At close: Sep 4, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Total Liabilities (2022 - 2026)

Adlai Nortye (ANL) posted quarterly Total Liabilities of $42.8 million for Q4 2025, down 6.62% year-over-year from $45.8 million in Q4 2024, and down 33.32% quarter-over-quarter from $64.1 million in Q2 2025.

Analysis

Adlai Nortye (ANL) Total Liabilities (2022 - 2026) Analysis & Trends

Adlai Nortye (ANL) has reported Total Liabilities for 4 consecutive years, with $42.8 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Total Liabilities fell 6.62% year-over-year to $42.8 million; the TTM figure through Dec 2025 stood at $42.8 million (down 6.62% YoY), while the FY2025 annual figure was $42.8 million, down 6.62% from the prior year.
  • Total Liabilities fell to $42.8 million in Q4 2025 per ANL's latest filing, from $64.1 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $313.9 million in Q4 2022 and bottomed at $42.8 million in Q4 2025.
  • Historically, Total Liabilities has averaged $96.0 million across 4 years, with a median of $54.7 million in 2023.
  • Annual changes were most pronounced in 2023 — Total Liabilities tumbled 82.43% — and 2025, when it increased 18.06%.
  • Adlai Nortye's Total Liabilities stood at $313.9 million in 2022, then sank by 82.43% to $55.1 million in 2023, then slipped by 16.97% to $45.8 million in 2024, then fell by 6.62% to $42.8 million in 2025.
  • Business Quant data shows ANL's Total Liabilities at $42.8 million in Q4 2025, $64.1 million in Q2 2025, and $45.8 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.62 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 4.20 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 1.72 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 4.00 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 10.03 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.35 Bn
10 Adlai Nortye 500.08 Mn 268.19 Mn - 33.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.53 Mn
Dec 31, 2025 42.76 Mn
Jun 30, 2025 64.12 Mn
Dec 31, 2024 45.79 Mn
Jun 30, 2024 54.31 Mn
Dec 31, 2023 55.14 Mn
Dec 31, 2022 313.89 Mn